ExCEEd Orphan

ExCEEd Orphan has successfully launched various orphan drugs in different therapeutic areas (hematology, immunology, metabolic diseases, nephrology, neurology, etc.) across Central and Eastern European countries. In summary, we have over 100 years of experience in the rare disease field. We will ensure that your drug reaches the maximum possible number of patients with rare diseases in Central and Eastern European countries. We provide tailored comprehensive services based on your business needs, goals, and strategy in the Central and Eastern European region.